These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8578489)

  • 1. Clinical trials of primary and secondary prevention of thrombosis and restenosis.
    Vermylen J
    Thromb Haemost; 1995 Jul; 74(1):377-81. PubMed ID: 8578489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
    Popma JJ; Satler LF
    J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
    Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventional therapy for coronary artery disease.
    Shah PB; Lilly CM
    Am J Respir Crit Care Med; 2002 Sep; 166(6):791-6. PubMed ID: 12231486
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiplatelet and anticoagulant therapy in patients undergoing percutaneous transluminal coronary angioplasty.
    Barry WL; Sarembock IJ
    Cardiol Clin; 1994 Aug; 12(3):517-35. PubMed ID: 7805084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?
    Lincoff AM; Topol EJ
    Eur Heart J; 2000 Jun; 21(11):863-7. PubMed ID: 10806004
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
    Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current approach in antithrombotic treatment during coronary interventions: specific thrombocyte aggregation inhibitors and direct thrombin antagonists in high-risk patients].
    Meyer BJ
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1961-9. PubMed ID: 8984604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet inhibitors and antioxidant vitamins in cardiovascular disease.
    Hennekens CH
    Am Heart J; 1994 Dec; 128(6 Pt 2):1333-6. PubMed ID: 7977015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy for patients with cardiac disease.
    Penny WJ; Chesebro JH; Heras M; Fuster V
    Curr Probl Cardiol; 1988 Jul; 13(7):433-513. PubMed ID: 3077928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Antiplatelet Treatment on Endothelial Function.
    Androulakis E; Norrington K; Bakogiannis C; Lioudaki E; Siasos G; Tousoulis D
    Curr Pharm Des; 2016; 22(29):4512-4518. PubMed ID: 27262335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidant vitamins and coronary heart disease risk.
    Clifton PM
    Curr Opin Lipidol; 1995 Feb; 6(1):20-4. PubMed ID: 7735709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy.
    Peter K; Lip GY
    Thromb Haemost; 2010 May; 103(5):875-6. PubMed ID: 20390222
    [No Abstract]   [Full Text] [Related]  

  • 17. Pleiotropic effects of statins and their clinical significance.
    LaRosa JC
    Am J Cardiol; 2001 Aug; 88(3):291-3. PubMed ID: 11472710
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of thrombosis and rethrombosis. New approaches.
    Runge MS
    Circulation; 1990 Aug; 82(2):655-7. PubMed ID: 2372913
    [No Abstract]   [Full Text] [Related]  

  • 19. Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland.
    Steinberg D
    Circulation; 1992 Jun; 85(6):2337-44. PubMed ID: 1591855
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of antioxidants in the prevention of cardiovascular disease].
    Páramo JA; Orbe MJ; Rodríguez JA
    Med Clin (Barc); 2001 May; 116(16):629-35. PubMed ID: 11412651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.